ASTRAZENECA PLC (AZN) News

AstraZeneca PLC Faces Class Action Lawsuit from Shareholders

Published on January 1, 2025

AstraZeneca PLC, a renowned pharmaceutical company, is facing a class action lawsuit from shareholders who have suffered substantial losses. The shareholders, represented by Levi Korsinsky, a leading law firm, are urging others who have also lost mo...

Investors Encouraged to Join Class Action Lawsuit Against AstraZeneca PLC

Published on December 31, 2024

Shareholders who have suffered financial losses with AstraZeneca PLC (AZN) are being urged to join a class-action lawsuit....

Promising Future: AstraZeneca PLC's Cutting-Edge Innovations Set to Revolutionize the Medical Industry

Published on December 30, 2024

In the ever-evolving world of pharmaceuticals, AstraZeneca PLC (AZN) continues to stand out as a trailblazer....

AstraZeneca PLC: A Leading European Dividend Stock with Promising Prospects

Published on December 30, 2024

AstraZeneca PLC (AZN) has emerged as one of the best European dividend stocks with immense growth potential....

Why Is AstraZeneca PLC AZN Among the Best European Dividend Stocks To Buy Now

Published on December 28, 2024

AstraZeneca PLC (AZN) has emerged as one of the top European dividend stocks to consider investing in....

AstraZeneca Faces Investigation in China; Shares Plummet

Published on December 26, 2024

AstraZeneca PLC (AZN) shares dropped significantly today following reports of a probe by the People's Republic of China (PRC) into alleged fraud and corruption within the company. The investigation comes as a major blow to one of Europe's leading pha...

AstraZeneca PLC Faces Investigation by the People's Republic of China (PRC)

Published on December 25, 2024

Shares of AstraZeneca PLC (AZN) have experienced a significant decline following recent reports of a probe launched by the People's Republic of China (PRC). The investigation is focused on allegations of fraud and corruption within the company's oper...

AstraZeneca: Shares Drop Amidst Reports of PRC Investigation

Published on December 24, 2024

AstraZeneca PLC, a leading pharmaceutical company, saw a decline in its shares following reports of a probe initiated by the People's Republic of China (PRC). The investigation revolves around alleged fraud and corruption within the company. As a res...

AstraZeneca PLC Faces Investigation After Allegations of Fraud and Corruption

Published on December 24, 2024

AstraZeneca PLC, a global pharmaceutical company, has recently been hit with allegations of fraud and corruption, causing its shares to plummet. The People's Republic of China (PRC) has initiated an investigation into the company's practices after re...

AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline

Published on December 21, 2024

AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption. The Chinese regulator is conducting an investigation into AstraZeneca's ...

AstraZeneca PLC Announcement: If You Have Suffered Losses in AstraZeneca PLC NASDAQ: AZN You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Published on December 20, 2024

AstraZeneca PLC, a renowned pharmaceutical company, has recently made an important announcement for shareholders who have suffered losses in their investments. If you are one of the affected individuals who has invested in AstraZeneca PLC on the NAS...

Is AstraZeneca PLC AZN the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Published on December 20, 2024

Recently, hedge funds have been showing increasing interest in AstraZeneca PLC (AZN) as a potential investment opportunity in the weight loss industry. With an innovative pipeline of drugs focusing on obesity treatment, AstraZeneca is poised to disru...

AstraZeneca PLC AZN: A Promising Investment Amidst Ongoing Securities Class Action Investigation

Published on December 18, 2024

Despite recent reports of a securities class action investigation, AstraZeneca PLC (AZN) remains a compelling investment opportunity. Hedge funds consider AZN as the best weight loss stock to buy now. The company has shown promising developments in i...

AstraZeneca Faces Investigation by PRC, Shares Plummet

Published on December 17, 2024

AstraZeneca, the pharmaceutical giant, is under investigation by the People's Republic of China (PRC) due to allegations of fraud and corruption. This news has caused a sharp decline in the company's shares. The PRC probe has raised serious concerns ...

AstraZeneca AZN Shares Fall After Reports of PRC Probe

Published on December 16, 2024

AstraZeneca PLC, a leading pharmaceutical company, has seen a drop in its shares following reports of a probe by the People's Republic of China (PRC). The PRC is investigating alleged fraud and corruption within AstraZeneca, causing concern among inv...

AstraZeneca AZN Faces Investigation Following Allegations of Fraud and Corruption

Published on December 15, 2024

AstraZeneca PLC, a leading pharmaceutical company, is facing a probe initiated by the People's Republic of China (PRC) following allegations of fraud and corruption. The PRC has launched an investigation into the company's business practices after re...

Hagens Berman Alleges Fraud and Corruption in AstraZeneca AZN; Shares Plummet

Published on December 14, 2024

Leading law firm Hagens Berman has initiated an investigation into British pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) following reports of potential fraud and corruption within the company. The allegations claim that AstraZeneca has been invol...

Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC

Published on December 13, 2024

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000. This new investment highlights the confidence that the advisory group has in the long-term potential of ...

Why Astrazeneca AZN is a Top Value Stock for the Long-Term

Published on December 12, 2024

AstraZeneca PLC (LON:AZN) has recently been identified as a top value stock for long-term investors....

AstraZeneca Faces Investigation by Chinese Authorities

Published on December 12, 2024

AstraZeneca PLC (AZN) shares experienced a decline in value following reports of a probe by the People's Republic of China (PRC). The investigation is centered around alleged fraud and corruption within the company. The news has disappointed investor...

Hilltop Holdings Inc. Acquires Shares of 9368 AstraZeneca PLC NASDAQ:AZN

Published on December 11, 2024

AstraZeneca PLC (NASDAQ: AZN) has recently witnessed a significant acquisition of shares by Hilltop Holdings Inc....

AstraZeneca PLC: A Leading Pharmaceutical Company with Strong Momentum

Published on December 10, 2024

AstraZeneca PLC (AZN) is a renowned pharmaceutical company that has been experiencing strong momentum in the market....

Heres Why Astrazeneca AZN is a Strong Momentum Stock